RA, rheumatoid arthritis; SSc, systemic sclerosis; ILD, interstitial lung disease; ANA, antinuclear antibodies; RF, rheumatoid factor; ACPA, anti-citrullinated protein antibodies; ATA, anti-topoisomerase antibodies. This evidence concerns the gene PRTN3 and interstitial lung disease.